Snapshot

The Emergency Use Authorization pathway has been developed by the of Mexico.

This pathway can be used where COVID-19 vaccines..

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

The complete evaluation process usually lasts 240 calendar days, excluding the New Molecules Committee evaluation time that usually lasts 4 weeks. The process, as per the homologation with the WHO prequalification scheme, usually lasts 60 working days. After the COFEPRIS evaluation of the submitted information, COFEPRIS can ask for more technical or administrative information if there is lacking or inconsistent information.